+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid udca vs silymarin sily in patients with active cirrhosis



Ursodeoxycholic acid udca vs silymarin sily in patients with active cirrhosis



Hepatology 12(4 Part 2): 957




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144962

Download citation: RISBibTeXText


Related references

Effect of ursodeoxycholic acid udca on liver function lf in patients with chronic active hepatitis and cirrhosis. European Journal of Clinical Investigation 20(2 Part 2): A62, 1990

Ursodeoxycholic acid udca in active cirrhosis influence of hepatitis c virus hcv infection. Journal of Hepatology 13(Suppl. 2): S139, 1991

Silymarin vs ursodeoxycholic acid in active cirrhosis a controlled cross over study. Journal of Hepatology 11((Suppl ) ): s98, 1985

Effect of udca and silymarin on liver function in patients with chronic active hepatitis with cirrhosis a prospective study. Journal of Hepatology 9(Suppl. 1): S184, 1989

Influence of ursodeoxycholic acid udca on bile acid metabolism of patients with primary biliary cirrhosis pbc. Gastroenterology 98(5 Part 2): A590, 1990

Ursodeoxycholic acid udca influences immune parameters in patients with primary biliary cirrhosis pbc. Hepatology 12(4 Part 2): 957, 1990

Does ursodeoxycholic acid udca influence cell membrane architecture in patients with primary biliary cirrhosis pbc. Gastroenterology 96(5 Part 2): A621, 1989

Silymarin for patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Gastroenterology 118(4 Suppl 2 Part 1): AASLD A901, 2000

Effects of different doses of ursodeoxycholic acid udca on liver function indices in patients with icteric primary biliary cirrhosis pbc. Gastroenterology 96(5 Part 2): A575, 1989

Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology 32(5): 897-900, 2000

Effects of lovastatin ls ursodeoxycholic acid udca and ls plus udca on bile lipid composition in patients with cholesterol ch gallstones. Gastroenterology 102(4 Part 2): A319, 1992

Sulindac and ursodeoxycholic acid improve primary biliary cirrhosis in patients not responding to UDCA A prospective controlled pilot study. Hepatology 32(4 Pt 2): 309A, 2000

Ursodeoxycholic acid udca improves serum protein level in patients with chronic active hepatitis. Hepatology 12(4 Part 2): 998, 1990